speb/financial-data huggingface dataset:
HIPO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 24148308.00
HIPO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2900000.00
HIPO income_statement (annual, 2023-12-31) — Other Gand A: 79600000.00
HIPO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 75700000.00
HIPO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2900000.00
HIPO income_statement (annual, 2023-12-31) — Other Operating Expenses: 46200000.00
HIPO balance_sheet (annual, 2023-12-31) — Other Receivables: 73800000.00
HIPO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 348800000.00
HIPO balance_sheet (annual, 2023-12-31) — Payables: 286400000.00
HIPO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 286400000.00
HIPO income_statement (annual, 2023-12-31) — Policyholder Benefits Ceded: 361800000.00
HIPO income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 622600000.00
HIPO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 346900000.00
HIPO income_statement (annual, 2023-12-31) — Pretax Income: -262500000.00
HIPO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -409600000.00
HIPO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -29600000.00
HIPO balance_sheet (annual, 2023-12-31) — Receivables: 505900000.00
HIPO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 19800000.00
HIPO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1800000.00
HIPO balance_sheet (annual, 2023-12-31) — Retained Earnings: -1234400000.00
HIPO income_statement (annual, 2023-12-31) — Salaries And Wages: 12500000.00
HIPO cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
HIPO cash_flow (annual, 2023-12-31) — Sale Of Investment: 517100000.00
HIPO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 80100000.00
HIPO income_statement (annual, 2023-12-31) — Selling General And Administration: 159700000.00
HIPO balance_sheet (annual, 2023-12-31) — Share Issued: 24148308.00
HIPO income_statement (annual, 2023-12-31) — Special Income Charges: -5500000.00
HIPO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 57500000.00
HIPO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 377900000.00
HIPO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 302200000.00
HIPO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1155000.00
HIPO income_statement (annual, 2023-12-31) — Tax Provision: 500000.00
HIPO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
HIPO balance_sheet (annual, 2023-12-31) — Total Assets: 1524700000.00
HIPO balance_sheet (annual, 2023-12-31) — Total Capitalization: 377900000.00
HIPO balance_sheet (annual, 2023-12-31) — Total Debt: 14800000.00
HIPO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 384700000.00
HIPO income_statement (annual, 2023-12-31) — Total Expenses: 472200000.00
HIPO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1140000000.00
HIPO income_statement (annual, 2023-12-31) — Total Unusual Items: -5500000.00
HIPO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5500000.00
HIPO income_statement (quarterly, 2024-09-30) — Amortization: 4300000.00
HIPO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
HIPO cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: 46800000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 14700000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: -4900000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: -100000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: -200000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Payable: 14700000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: 9800000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: -1000000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Receivables: 13200000.00
HIPO cash_flow (quarterly, 2024-09-30) — Change In Working Capital: 47000000.00
HIPO cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 20600000.00
HIPO cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
HIPO cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 5900000.00
HIPO income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 4300000.00
HIPO income_statement (quarterly, 2024-09-30) — Interest Income: 2300000.00
HIPO cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: -5200000.00
HIPO cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: -1700000.00
HIPO income_statement (quarterly, 2024-09-30) — Other Special Charges: -8200000.00
HIPO income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 4300000.00
HIPO cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
HIPO income_statement (quarterly, 2024-09-30) — Salaries And Wages: 3200000.00
HIPO cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 9000000.00
HIPO income_statement (annual, 2024-12-31) — +Total Revenue: 372100000.00
HIPO balance_sheet (annual, 2024-12-31) — Accounts Payable: 267900000.00
HIPO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 453100000.00
HIPO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1639700000.00
HIPO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 3300000.00
HIPO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
HIPO income_statement (annual, 2024-12-31) — Basic Average Shares: 24699913.00
HIPO income_statement (annual, 2024-12-31) — Basic EPS: -1.64
HIPO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 195100000.00
HIPO cash_flow (annual, 2024-12-31) — Capital Expenditure: -12000000.00
HIPO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -11700000.00
HIPO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 10000000.00
HIPO balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
HIPO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 197600000.00
HIPO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 570900000.00
HIPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -40100000.00
HIPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 30300000.00
HIPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 47500000.00
HIPO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -6400000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Account Payable: -11500000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -12600000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -17500000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: -8100000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -6400000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -200000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 9700000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 3300000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Payable: -11500000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Payable: -12600000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -29000000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -20700000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 61400000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 18100000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Receivables: -31600000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -5200000.00
HIPO cash_flow (annual, 2024-12-31) — Change In Working Capital: 70300000.00
HIPO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -21700000.00
HIPO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -25900000.00
HIPO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -14800000.00
HIPO cash_flow (annual, 2024-12-31) — Changes In Cash: 37700000.00
HIPO balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
HIPO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 362100000.00
HIPO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 6700000.00
HIPO cash_flow (annual, 2024-12-31) — Common Stock Payments: -15600000.00
HIPO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -15600000.00
HIPO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 23200000.00
HIPO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 5800000.00
HIPO income_statement (annual, 2024-12-31) — Diluted Average Shares: 24699913.00
HIPO income_statement (annual, 2024-12-31) — Diluted EPS: -1.64
HIPO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -40500000.00
HIPO balance_sheet (annual, 2024-12-31) — Employee Benefits: 5800000.00
HIPO cash_flow (annual, 2024-12-31) — End Cash Position: 232800000.00
HIPO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -40100000.00
HIPO cash_flow (annual, 2024-12-31) — Free Cash Flow: 35500000.00
HIPO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1700000.00
HIPO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -54400000.00
HIPO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -46200000.00
HIPO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -2700000.00
HIPO income_statement (annual, 2024-12-31) — General And Administrative Expense: 70700000.00
HIPO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 65100000.00
HIPO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 3600000.00
HIPO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
HIPO income_statement (annual, 2024-12-31) — Interest Income: 9900000.00
HIPO income_statement (quarterly, 2024-12-31) — Interest Income: 2600000.00
HIPO balance_sheet (annual, 2024-12-31) — Invested Capital: 362100000.00
HIPO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 30300000.00
HIPO balance_sheet (annual, 2024-12-31) — Investments And Advances: 373300000.00
HIPO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 6700000.00
HIPO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 10000000.00
HIPO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 10000000.00
HIPO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 34300000.00
HIPO income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 297800000.00
HIPO balance_sheet (annual, 2024-12-31) — Minority Interest: 3100000.00
HIPO balance_sheet (quarterly, 2024-12-31) — Minority Interest: 3100000.00
HIPO income_statement (annual, 2024-12-31) — Minority Interests: -11900000.00
HIPO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 67200000.00
HIPO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 48000000.00
HIPO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -8900000.00
HIPO income_statement (annual, 2024-12-31) — Net Income: -40500000.00
HIPO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -40500000.00
HIPO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -28600000.00
HIPO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -40500000.00
HIPO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -40500000.00
HIPO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -28600000.00
HIPO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 46900000.00
HIPO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -28600000.00
HIPO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -30900000.00
HIPO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -31200000.00
HIPO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 6000000.00
HIPO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 5800000.00
HIPO balance_sheet (annual, 2024-12-31) — Net PPE: 37700000.00
HIPO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -300000.00
HIPO income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 297800000.00
HIPO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 297000000.00
HIPO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 8000000.00
HIPO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 8000000.00
HIPO income_statement (annual, 2024-12-31) — Normalized Income: -80632000.00
HIPO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 47500000.00
HIPO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -54400000.00
HIPO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -46200000.00
HIPO income_statement (annual, 2024-12-31) — Operating Revenue: 372100000.00
HIPO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 24866803.00
HIPO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -2700000.00
HIPO income_statement (annual, 2024-12-31) — Other Gand A: 70700000.00
HIPO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 65100000.00
HIPO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -4500000.00
HIPO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -100000.00
HIPO income_statement (annual, 2024-12-31) — Other Operating Expenses: 30600000.00
HIPO balance_sheet (annual, 2024-12-31) — Other Receivables: 79500000.00
HIPO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 373300000.00
HIPO income_statement (annual, 2024-12-31) — Other Special Charges: -54400000.00
HIPO income_statement (quarterly, 2024-12-31) — Other Special Charges: -46200000.00
HIPO balance_sheet (annual, 2024-12-31) — Payables: 267900000.00
HIPO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 267900000.00
HIPO income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 241300000.00
HIPO income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 539100000.00
HIPO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 280800000.00
HIPO income_statement (annual, 2024-12-31) — Pretax Income: -27400000.00
HIPO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -367800000.00
HIPO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -300000.00
HIPO balance_sheet (annual, 2024-12-31) — Receivables: 532600000.00
HIPO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 23200000.00
HIPO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 5800000.00
HIPO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -15600000.00
HIPO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -15600000.00
HIPO balance_sheet (annual, 2024-12-31) — Retained Earnings: -1274900000.00
HIPO cash_flow (annual, 2024-12-31) — Sale Of Business: 67200000.00
HIPO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 48000000.00
HIPO cash_flow (annual, 2024-12-31) — Sale Of Investment: 336900000.00
HIPO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 51200000.00
HIPO income_statement (annual, 2024-12-31) — Selling General And Administration: 121900000.00
HIPO balance_sheet (annual, 2024-12-31) — Share Issued: 24866803.00
HIPO income_statement (annual, 2024-12-31) — Special Income Charges: 50800000.00
HIPO income_statement (quarterly, 2024-12-31) — Special Income Charges: 46200000.00
HIPO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 38200000.00
HIPO cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 8900000.00
HIPO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 362100000.00
HIPO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 297000000.00
HIPO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 10668000.00
HIPO income_statement (annual, 2024-12-31) — Tax Provision: 1200000.00
HIPO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
HIPO balance_sheet (annual, 2024-12-31) — Total Assets: 1543400000.00
HIPO balance_sheet (annual, 2024-12-31) — Total Capitalization: 362100000.00
HIPO balance_sheet (annual, 2024-12-31) — Total Debt: 10000000.00
HIPO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 365200000.00
HIPO income_statement (annual, 2024-12-31) — Total Expenses: 399500000.00
HIPO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1178200000.00
HIPO income_statement (annual, 2024-12-31) — Total Unusual Items: 50800000.00
HIPO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 46200000.00
HIPO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 50800000.00
HIPO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 46200000.00
HIPO income_statement (quarterly, 2025-03-31) — +Total Revenue: 110300000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 261500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 499800000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1646000000.00
HIPO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 24978901.00
HIPO income_statement (quarterly, 2025-03-31) — Basic EPS: -1.91
HIPO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 232800000.00
HIPO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2900000.00
HIPO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -2800000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 8900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
HIPO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 140900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 392800000.00
HIPO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -6000000.00
HIPO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -11000000.00
HIPO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -52600000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
HIPO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 322800000.00
HIPO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1000000.00
HIPO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 24978901.00
HIPO income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.91
HIPO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -47700000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 5200000.00
HIPO cash_flow (quarterly, 2025-03-31) — End Cash Position: 180200000.00
HIPO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -6000000.00
HIPO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -38500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -600000.00
HIPO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 63500000.00
HIPO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
HIPO income_statement (quarterly, 2025-03-31) — Interest Income: 2100000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 322800000.00
HIPO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -11000000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 388300000.00
HIPO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1000000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 8900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 38700000.00
HIPO income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 122600000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 2900000.00
HIPO income_statement (quarterly, 2025-03-31) — Minority Interests: -2300000.00
HIPO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1000000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income: -47700000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -47700000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -45400000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -47700000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -47700000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -45400000.00
HIPO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -8100000.00
HIPO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -7000000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Net PPE: 36700000.00
HIPO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -100000.00
HIPO income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 122600000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 259300000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10700000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 10700000.00
HIPO income_statement (quarterly, 2025-03-31) — Normalized Income: -47700000.00
HIPO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -35600000.00
HIPO income_statement (quarterly, 2025-03-31) — Operating Revenue: 110300000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 25157214.00
HIPO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -600000.00
HIPO income_statement (quarterly, 2025-03-31) — Other Gand A: 16500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 63500000.00
HIPO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 7900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 85700000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 251900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Payables: 261500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 261500000.00
HIPO income_statement (quarterly, 2025-03-31) — Policyholder Benefits Ceded: 119400000.00
HIPO income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 242000000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 255600000.00
HIPO income_statement (quarterly, 2025-03-31) — Pretax Income: -45600000.00
HIPO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -66100000.00
HIPO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -100000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Receivables: 585500000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1322600000.00
HIPO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 58000000.00
HIPO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 8900000.00
HIPO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 25400000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Share Issued: 25157214.00
HIPO income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
HIPO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 322800000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 259300000.00
HIPO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HIPO income_statement (quarterly, 2025-03-31) — Tax Provision: -200000.00
HIPO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
HIPO balance_sheet (quarterly, 2025-03-31) — Total Assets: 1540400000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 322800000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Total Debt: 8900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 325700000.00
HIPO income_statement (quarterly, 2025-03-31) — Total Expenses: 155900000.00
HIPO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1214700000.00
HIPO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
HIPO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HIPO income_statement (quarterly, 2025-06-30) — +Total Revenue: 117300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 322700000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 530900000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1653700000.00
HIPO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 25343457.00
HIPO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.05
HIPO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 180200000.00
HIPO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3400000.00
HIPO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -3500000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6100000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
HIPO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 198900000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 454000000.00
HIPO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 42800000.00
HIPO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -21900000.00
HIPO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 45600000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
HIPO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 332500000.00
HIPO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26023780.00
HIPO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.05
HIPO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 5200000.00
HIPO cash_flow (quarterly, 2025-06-30) — End Cash Position: 225800000.00
HIPO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 42800000.00
HIPO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 21300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 100000.00
HIPO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 17400000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 61500000.00
HIPO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1200000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 380400000.00
HIPO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -21900000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 405100000.00
HIPO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6100000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 47900000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 54000000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 38400000.00
HIPO income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 77300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1600000.00
HIPO income_statement (quarterly, 2025-06-30) — Minority Interests: -2600000.00
HIPO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 3900000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1300000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 3900000.00
HIPO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -18500000.00
HIPO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 41500000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Net PPE: 34300000.00
HIPO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 100000.00
HIPO income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 77300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 271000000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 13800000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 13800000.00
HIPO income_statement (quarterly, 2025-06-30) — Normalized Income: 2470000.00
HIPO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 24700000.00
HIPO income_statement (quarterly, 2025-06-30) — Operating Revenue: 117300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 25543053.00
HIPO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 100000.00
HIPO income_statement (quarterly, 2025-06-30) — Other Gand A: 17400000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 61500000.00
HIPO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 8200000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 107700000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 255100000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Payables: 322700000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 322700000.00
HIPO income_statement (quarterly, 2025-06-30) — Policyholder Benefits Ceded: 43300000.00
HIPO income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 120600000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 302800000.00
HIPO income_statement (quarterly, 2025-06-30) — Pretax Income: 4000000.00
HIPO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -132000000.00
HIPO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 100000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Receivables: 638600000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1321300000.00
HIPO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 113500000.00
HIPO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 9200000.00
HIPO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 26600000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Share Issued: 25543053.00
HIPO income_statement (quarterly, 2025-06-30) — Special Income Charges: -1200000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 332500000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 271000000.00
HIPO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -30000.00
HIPO income_statement (quarterly, 2025-06-30) — Tax Provision: 100000.00
HIPO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.03
HIPO balance_sheet (quarterly, 2025-06-30) — Total Assets: 1706200000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 380400000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Total Debt: 54000000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 334100000.00
HIPO income_statement (quarterly, 2025-06-30) — Total Expenses: 113300000.00
HIPO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1372100000.00
HIPO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1200000.00
HIPO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1200000.00
HIPO income_statement (quarterly, 2025-09-30) — +Total Revenue: 120600000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 349200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 559300000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1643300000.00
HIPO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 25183389.00
HIPO income_statement (quarterly, 2025-09-30) — Basic EPS: 3.90
HIPO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 225800000.00
HIPO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3500000.00
HIPO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -3400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 5300000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
HIPO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 247700000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 520900000.00
HIPO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -17900000.00
HIPO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 47400000.00
HIPO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 46400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
HIPO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 421500000.00
HIPO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 500000.00
HIPO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 26025069.00
HIPO income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.77
HIPO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 98100000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 9500000.00
HIPO cash_flow (quarterly, 2025-09-30) — End Cash Position: 272200000.00
HIPO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -17900000.00
HIPO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 13400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1400000.00
HIPO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 16500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 57300000.00
HIPO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 3800000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 469400000.00
HIPO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 47400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 420200000.00
HIPO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5300000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 47900000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 53200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 38000000.00
HIPO income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 80400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 0.00
HIPO income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
HIPO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -14000000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income: 98100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 98100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 98100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 98100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 98100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 98100000.00
HIPO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -14900000.00
HIPO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3900000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Net PPE: 33800000.00
HIPO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -100000.00
HIPO income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 80400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 364200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 13400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 13400000.00
HIPO income_statement (quarterly, 2025-09-30) — Normalized Income: 6900000.00
HIPO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 16900000.00
HIPO income_statement (quarterly, 2025-09-30) — Operating Revenue: 120600000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 25337366.00
HIPO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1400000.00
HIPO income_statement (quarterly, 2025-09-30) — Other Gand A: 16500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 57300000.00
HIPO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 8800000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 123100000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 273200000.00
HIPO income_statement (quarterly, 2025-09-30) — Other Special Charges: -95000000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Payables: 349200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 349200000.00
HIPO income_statement (quarterly, 2025-09-30) — Policyholder Benefits Ceded: 53100000.00
HIPO income_statement (quarterly, 2025-09-30) — Policyholder Benefits Gross: 133500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 344200000.00
HIPO income_statement (quarterly, 2025-09-30) — Pretax Income: 98100000.00
HIPO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -101500000.00
HIPO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -100000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Receivables: 682400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1223200000.00
HIPO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 86600000.00
HIPO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 8000000.00
HIPO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 24500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Share Issued: 25337366.00
HIPO income_statement (quarterly, 2025-09-30) — Special Income Charges: 91200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 421500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 364200000.00
HIPO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HIPO income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
HIPO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
HIPO balance_sheet (quarterly, 2025-09-30) — Total Assets: 1873600000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 469400000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Total Debt: 53200000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 421500000.00
HIPO income_statement (quarterly, 2025-09-30) — Total Expenses: 22500000.00
HIPO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1452100000.00
HIPO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 91200000.00
HIPO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 91200000.00
HIPO income_statement (annual, 2025-12-31) — +Total Revenue: 468600000.00
HIPO income_statement (quarterly, 2025-12-31) — +Total Revenue: 120400000.00
HIPO balance_sheet (annual, 2025-12-31) — Accounts Payable: 319300000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 319300000.00
HIPO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 597600000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 597600000.00
HIPO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1651500000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1651500000.00
HIPO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 5000000.00
HIPO income_statement (annual, 2025-12-31) — Basic Average Shares: 25253520.00
HIPO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 25503339.00
HIPO income_statement (annual, 2025-12-31) — Basic EPS: 2.28
HIPO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.24
HIPO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 232800000.00
HIPO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 272200000.00
HIPO cash_flow (annual, 2025-12-31) — Capital Expenditure: -13300000.00
HIPO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3500000.00
HIPO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -13200000.00
HIPO cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -3500000.00
HIPO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4500000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4500000.00
HIPO balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
HIPO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
HIPO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 218300000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 218300000.00
HIPO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 472000000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 472000000.00
HIPO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 19300000.00
HIPO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 400000.00
HIPO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11200000.00
HIPO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -25700000.00
HIPO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9200000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Account Payable: 55800000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 7400000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -16200000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2000000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Payable: 55800000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 63200000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -79500000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Receivables: -165900000.00
HIPO cash_flow (annual, 2025-12-31) — Change In Working Capital: -4200000.00
HIPO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -146700000.00
HIPO cash_flow (annual, 2025-12-31) — Changes In Cash: 17300000.00
HIPO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -22100000.00
HIPO balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
HIPO balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
HIPO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 436100000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 436100000.00
HIPO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3800000.00
HIPO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1000000.00
HIPO cash_flow (annual, 2025-12-31) — Common Stock Payments: -14500000.00
HIPO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
HIPO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 20400000.00
HIPO income_statement (annual, 2025-12-31) — Diluted Average Shares: 26011391.00
HIPO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26245980.00
HIPO income_statement (annual, 2025-12-31) — Diluted EPS: 2.22
HIPO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.23
HIPO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 57700000.00
HIPO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 6000000.00
HIPO balance_sheet (annual, 2025-12-31) — Employee Benefits: 9000000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 9000000.00
HIPO cash_flow (annual, 2025-12-31) — End Cash Position: 250100000.00
HIPO cash_flow (quarterly, 2025-12-31) — End Cash Position: 250100000.00
HIPO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 19300000.00
HIPO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 400000.00
HIPO cash_flow (annual, 2025-12-31) — Free Cash Flow: -4100000.00
HIPO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -300000.00
HIPO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -95000000.00
HIPO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1800000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1800000.00
HIPO income_statement (annual, 2025-12-31) — General And Administrative Expense: 67100000.00
HIPO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 16700000.00
HIPO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 56800000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 56800000.00
HIPO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 5000000.00
HIPO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
HIPO balance_sheet (annual, 2025-12-31) — Invested Capital: 484000000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 484000000.00
HIPO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -11200000.00
HIPO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -25700000.00
HIPO balance_sheet (annual, 2025-12-31) — Investments And Advances: 445900000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 445900000.00
HIPO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3800000.00
HIPO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1000000.00
HIPO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4500000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4500000.00
HIPO balance_sheet (annual, 2025-12-31) — Long Term Debt: 47900000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 47900000.00
HIPO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 52400000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 52400000.00
HIPO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 36300000.00
HIPO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 36300000.00
HIPO income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 361200000.00
HIPO income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 80900000.00
HIPO balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
HIPO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
HIPO income_statement (annual, 2025-12-31) — Minority Interests: -4900000.00
HIPO income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
HIPO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 65800000.00
HIPO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
HIPO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -10700000.00
HIPO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1000000.00
HIPO income_statement (annual, 2025-12-31) — Net Income: 57700000.00
HIPO income_statement (quarterly, 2025-12-31) — Net Income: 6000000.00
HIPO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 57700000.00